Literature DB >> 12692070

Screening and surveillance for asymptomatic colorectal cancer in IBD.

A Forbes, S Gabe, J E Lennard-Jones, K Wilkinson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12692070      PMCID： PMC1773655          DOI： 10.1136/gut.52.5.769

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.

Authors:  J A Eaden; B A Ward; J F Mayberry
Journal:  Gastrointest Endosc       Date:  2000-02       Impact factor: 9.427

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.

Authors:  S N Gyde; P Prior; R N Allan; A Stevens; D P Jewell; S C Truelove; R Lofberg; O Brostrom; G Hellers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

4.  Screening: the legal view.

Authors:  J Eaden; M K Mayberry; A Sherr; J F Mayberry
Journal:  Public Health       Date:  2001-05       Impact factor: 2.427

5.  Crohn's disease and colorectal cancer.

Authors:  C D Gillen; H A Andrews; P Prior; R N Allan
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 6.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059
  6 in total
  2 in total

1.  British Society of Gastroenterology guidelines for ulcerative colitis surveillance: creating consensus or confusion?

Authors:  B Hudson; J Green
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 2.  5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.

Authors:  Yang Cheng; Pierre Desreumaux
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.